Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinicopathological features and prognostic factors of gastric intermediate-risk gastrointestinal stromal tumor after surgical resection: a retrospective study].

Zhonghua bing li xue za zhi = Chinese journal of pathology - 8 Apr 2023

Yuan W, Huang W, Ren L, Liang H Y, Du X Y, Fu M, Xu C, Fang Y, Shen K T, Hou Y Y

Abstract excerpt

Objective: To investigate the clinicopathological features, treatment and prognosis of gastric intermediate-risk gastrointestinal stromal tumor (GIST), so as to provide a reference for clinical management and further research. Methods: A retrospective observational study of patients with gastric intermediate-risk GIST, who underwent surgical resection between January 1996 and December 2019 at Zhongshan Hospital...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Gastrointestinal Stromal Tumors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imatinib Mesylate

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins c-kit

Source

Identifiers

PMID: 36973200
DOI: 10.3760/cma.j.cn112151-20220623-00548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinicopathological features and prognostic factors of gastric intermediate-risk gastrointestinal stromal tumor after surgical resection: a retrospective study].PMID 36973200Read ↗

Benefit of imatinib adjuvant therapy for patients with intermediate risk gastrointestinal stromal tumor: a multi-center retrospective analysis in ChinaSemantic proximity Read ↗

[Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].Semantic proximity Read ↗

Clinicopathologic features and prognosis of gastrointestinal stromal tumors: A retrospective studySemantic proximity Read ↗

Gastrointestinal stromal tumor.Semantic proximity Read ↗

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version.Semantic proximity Read ↗

[Interpretation on 2013 updated Chinese Consensus on the Diagnosis and Treatment of Gastrointestinal Stromal Tumors].Semantic proximity Read ↗

The GIST paradigm: how to establish diagnostic and prognostic criteria.Semantic proximity Read ↗

Clinicopathological Features and Gene Mutation Analysis of Gastrointestinal Stromal Tumors: A Series of 58 PatientsSemantic proximity Read ↗

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.Semantic proximity Read ↗

[Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].Semantic proximity Read ↗

Post-operative imatinib in patients with intermediate or high risk gastrointestinal stromal tumor.Semantic proximity Read ↗

Retrospective analysis of extra-gastrointestinal stromal tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.